Call us : USA : 1-631-381-2994; Europe : 44-207-097-1828
Mail us : info@creative-biolabs.com
Creative Biolabs Blog

Menu

Skip to content
  • Drug Discovery Research
  • Immunotherapy Research
  • Antibody Engineering Research

Category Archives: Immunotherapy Research

17Aug/17

The Introduction of T Cell Proliferation Assay  

August 17, 2017Immunotherapy ResearchCAR-T, T cell proliferation assay, TCR T cell culturebiolabs

Cell proliferation is an important vital sign of the organism in a splitting manner. Single-celled organisms produce new individuals in the form of cell division, while a multicellular organism that produces newRead More…

16Aug/17

Revelation! CAR-T Has Its “Eyes” on Solid Tumor and the Treatment of That Would Be Possible

August 16, 2017Immunotherapy Research, Newscancer, CAR-T, immunotherapy, tumorbiolabs

Immunotherapy has become a new hope against cancer. CAR-T cell therapy is achieved by using genetic engineering method to express chimeric antigen receptors on T cells obtained from donner patients. These chimericRead More…

14Aug/17

Comparison between CAR-T and TCR-T

August 14, 2017Immunotherapy ResearchCAR-T, high affinity TCRbiolabs

As a matter of fact, tumor immunotherapy is divided into two categories. One is to show immune cells the tumor features, then direct them to locate and kill tumor cells. And anotherRead More…

12Aug/17

TCR, A New Star of Immune Cell Therapy

August 12, 2017Immunotherapy ResearchCAR-T, TCR service,tumor specific TCR,tcr t productionbiolabs

Immune cell therapy, the fourth major cancer treatment following surgery, radiotherapy, and chemotherapy, has been recognized as the most active and promising treatment in the comprehensive tumor treatment in the 21st century.Read More…

08Aug/17

Signal, Migration and Survival of CAR T Cells

August 8, 2017Immunotherapy Researchcar t establish, CAR-T, CAR-T therapybiolabs

CAR-T, Chimeric AntigenReceptor T-Cell Immunotherapy, is the most effective treatment of malignant tumors. Similar to other immunotherapy, its basic principle is to remove cancer cells in the use of the patient’s ownRead More…

08Aug/17

A New Immunotherapy Called CAR-T Will Beat Cancer Surprisingly

August 8, 2017Immunotherapy ResearchCAR T scFV, CAR-Tbiolabs

CAR-T (Chimeric Antigen Receptor T-Cell), as an immunocytotherapy regimen, has attracted a lot of attention from academics, doctors, patients, and investors worldwide. What does make it so attractive and popular? CAR-T modifiesRead More…

24Jul/17

The First CAR-T Therapy Drug Is Approved and Recommended by FDA Experts Unanimously on a 10-0 Vote!

July 24, 2017Immunotherapy Research, NewsCAR-T, FDA, immunotherapy drug, Novartisbiolabs

Novartis’ chimeric antigen receptor T cell therapy (CAR-T) was supported and approved unanimously (10-0) on July 12th by the U.S. FDA Advisory Committee experts. This vote marks the key milepost of thisRead More…

22Jun/17

Will the First CAR-T Therapy Be Approved on July 12? —Novartis CTL019

June 22, 2017Immunotherapy Research, NewsCAR-T, CAR-T therapy, CTL019, Novartisbiolabs

On July 12, FDA experts will discuss whether CAR-T CTL019 can be on the market, which is an assessment of the CTL019 Biologics License Application (BLA) submitted by Novartis and will evaluateRead More…

05May/17

CAR-T’s Era Is Really Coming!

May 5, 2017Immunotherapy ResearchB-ALL, CAR-T, CD19biolabs

On March 29, 2017, Novartis announced that the US FDA has issued a priority review for its CAR-T therapy CTL019 (tisagenlecleucel-T) biologics licensing application. The indications of CTL019 was recurrent or refractoryRead More…

Posts navigation

  • « Previous
  • 1
  • 2
  • 3
  • 4

Categories

  • Antibody Engineering Research
  • Biological Knowledge
  • Drug Discovery Research
  • Immunotherapy Research
  • News

Recent Posts

  • Nat Methods: How to Enhance the Effect of T Cell Therapy?
  • New TCR Therapy—Tebentafusp
  • eLife: The New Anticancer Mechanism of T Cells
  • The Discoverers of Hepatitis C Virus Won the 2020 Nobel Prize in Physiology or Medicine
  • COVID-19 May Lead to the Loss of Important Immune Structure—It Is Expected to Explain the Cause of Secondary Infection in Recovered Patients

Archives

Contact Us

USA:
45-1 Ramsey Road, Shirley, NY 11967, USA
Tel: 1-631-381-2994
Fax: 1-631-207-8356
Email: info@creative-biolabs.com
Europe:
Tel: 44-207-097-1828

Copyright © Creative Biolabs Blog
Powered by WordPress , Designed and Developed by templatesnext